The Shifting Sands of Teza Capital Management: A Look at Q3 2022 Vs. Q4 2022 Holdings

Teza Capital Management LLC recently released its 13F holdings comparison report for Q3 2022 vs. Q4 2022. The report outlines the changes in holdings of various stocks and provides insight into the portfolio diversification strategy of this prestigious investment management firm. The report highlights an array of interesting changes, some of which are quite significant. This blog post will delve into the report and take a closer look at some of the most notable changes in holdings.

Introduction

Teza Capital Management LLC is amongst the most reputable investment management firms globally, with a wide range of investment funds under its management. The firm recently released its 13F holdings comparison report for Q3 2022 vs. Q4 2022. The comparison highlights the changes in holdings and values of various stocks in Teza's portfolio.

Main Body

Teza's portfolio saw significant changes during the last quarter, with some stocks' values increasing and others decreasing. One of the most noteworthy changes in holdings is the significant decrease in shares of Mondelez International Inc. (MDLZ) by 8.2%. However, other consumer goods stocks, such as Toll Brothers Inc. (TOL), and Walmart Inc. (WMT), saw an increase in Teza's holdings, with options shares rising to 722.5% and 4917% respectively.

Additionally, Teza's holdings in the financial services sector have shifted significantly. The firm increased its shares in US Bancorp Del (USB) by 56% and decreased its holdings in Goldman Sachs Group Inc. (GS) by 582.7%. The banking industry's focus seems to be on the future, with Citigroup Inc. (C) seeing a decrease in shares by 59.5%, whereas Citizens Financial Group, Inc. (CFG) saw a notable increase in holdings by 123.6%.

The comparison report also shows that Teza's technology holdings have taken a slight hit, with shares of Analog Devices Inc. (ADI) decreasing by 54.3%, whereas shares of Adobe Systems Incorporated (ADBE) increased by 158.1%.

The healthcare sector saw a lot of activity in Teza's portfolio, with some companies' shares increasing and others decreasing. For example, the firm increased its shares in the pharmaceutical company Biogen Inc. (BIIB) by 101.1%. In contrast, it decreased its holdings in the mental health firm Neurocrine Biosciences Inc. (NBIX) by 279.4%. Biogen's increase in shares could be attributed to the firm's success in developing treatments to tackle neurological disorders.

Conclusion

Teza Capital Management LLC's Q3 2022 vs. Q4 2022 13F holdings comparison report shows that the company made some interesting changes in its portfolio. The breadth of change in holdings indicates that the firm is innovative and continuously exploring ways to optimize its clients' returns. By staying ahead of the curve in the healthcare industry, Teza's investments seem to be well-positioned to achieve significant long-term growth, with the company's shares in Biogen Inc. and Toll Brothers Inc. providing excellent prospects for increased profitability.